These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 30677746)

  • 1. Impact of Apolipoprotein E gene polymorphism during normal and pathological conditions of the brain across the lifespan.
    Iacono D; Feltis GC
    Aging (Albany NY); 2019 Jan; 11(2):787-816. PubMed ID: 30677746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of apolipoprotein E polymorphism as a prognostic marker in traumatic brain injury and neurodegenerative disease: a critical review.
    Maiti TK; Konar S; Bir S; Kalakoti P; Bollam P; Nanda A
    Neurosurg Focus; 2015 Nov; 39(5):E3. PubMed ID: 26646927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOE and Alzheimer's Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer's Pathogenesis.
    Uddin MS; Kabir MT; Al Mamun A; Abdel-Daim MM; Barreto GE; Ashraf GM
    Mol Neurobiol; 2019 Apr; 56(4):2450-2465. PubMed ID: 30032423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the apolipoprotein E polymorphism, age and sex on neurogenesis in mice: pathophysiological relevance for Alzheimer's disease?
    Koutseff A; Mittelhaeuser C; Essabri K; Auwerx J; Meziane H
    Brain Res; 2014 Jan; 1542():32-40. PubMed ID: 24140109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOE-related biomarker profiles in non-pathological aging and early phases of Alzheimer's disease.
    Reinvang I; Espeseth T; Westlye LT
    Neurosci Biobehav Rev; 2013 Sep; 37(8):1322-35. PubMed ID: 23701948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ApoE and Neurodegenerative Diseases in Aging.
    Yin Y; Wang Z
    Adv Exp Med Biol; 2018; 1086():77-92. PubMed ID: 30232753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for dissecting genetic-environmental interactions in neurodegenerative disorders.
    Schmechel DE; Browndyke J; Ghio A
    Neurotoxicology; 2006 Sep; 27(5):637-57. PubMed ID: 16870258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism.
    Kamboh MI; Sanghera DK; Ferrell RE; DeKosky ST
    Nat Genet; 1995 Aug; 10(4):486-8. PubMed ID: 7670501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A polymorphism of the interleukin-1 beta gene at position +3953 influences progression and neuro-pathological hallmarks of Alzheimer's disease.
    Licastro F; Veglia F; Chiappelli M; Grimaldi LM; Masliah E
    Neurobiol Aging; 2004 Sep; 25(8):1017-22. PubMed ID: 15212826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of our genes: consequences of the apolipoprotein E polymorphism in Alzheimer disease and multiple sclerosis.
    Fazekas F; Enzinger C; Ropele S; Schmidt H; Schmidt R; Strasser-Fuchs S
    J Neurol Sci; 2006 Jun; 245(1-2):35-9. PubMed ID: 16631796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E4: an allele associated with many diseases.
    Smith JD
    Ann Med; 2000 Mar; 32(2):118-27. PubMed ID: 10766403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Apolipoproteins and cognitive deterioration].
    Bartrés-Faz D; Clemente I
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(6):380-90. PubMed ID: 9972590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E as a target for developing new therapeutics for Alzheimer's disease based on studies from protein, RNA, and regulatory region of the gene.
    Lahiri DK
    J Mol Neurosci; 2004; 23(3):225-33. PubMed ID: 15181251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SREBP-1a polymorphism influences the risk of Alzheimer's disease in carriers of the ApoE4 allele.
    Spell C; Kölsch H; Lütjohann D; Kerksiek A; Hentschel F; Damian M; von Bergmann K; Rao ML; Maier W; Heun R
    Dement Geriatr Cogn Disord; 2004; 18(3-4):245-9. PubMed ID: 15286454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral beta-amyloid deposition is augmented by the -491AA promoter polymorphism in non-demented elderly individuals bearing the apolipoprotein E epsilon4 allele.
    Pahnke J; Walker LC; Schroeder E; Vogelgesang S; Stausske D; Walther R; Warzok RW
    Acta Neuropathol; 2003 Jan; 105(1):25-9. PubMed ID: 12471457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E polymorphism and susceptibility to Alzheimer's disease.
    Kamboh MI
    Hum Biol; 1995 Apr; 67(2):195-215. PubMed ID: 7729825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's disease.
    Huang Y; Weisgraber KH; Mucke L; Mahley RW
    J Mol Neurosci; 2004; 23(3):189-204. PubMed ID: 15181247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in cognitive impairment diseases.
    Tisato V; Zuliani G; Vigliano M; Longo G; Franchini E; Secchiero P; Zauli G; Paraboschi EM; Vikram Singh A; Serino ML; Ortolani B; Zurlo A; Bosi C; Greco A; Seripa D; Asselta R; Gemmati D
    PLoS One; 2018; 13(3):e0193867. PubMed ID: 29518107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroimaging and APOE genotype: a systematic qualitative review.
    Cherbuin N; Leach LS; Christensen H; Anstey KJ
    Dement Geriatr Cogn Disord; 2007; 24(5):348-62. PubMed ID: 17911980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of APOE in dementia: A critical reappraisal.
    de Knijff P; van Duijn CM
    Haemostasis; 1998; 28(3-4):195-201. PubMed ID: 10420066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.